当前位置： SCI文献检索 > HUMAN GENE THERAPY期刊下所有文献 > Enhanced Transduction of Macaca fascicularis Hematopoietic Cells with Chimeric Lentiviral Vectors.

Enhanced Transduction of Macaca fascicularis Hematopoietic Cells with Chimeric Lentiviral Vectors.

Abstract：

:Recent marketing approval for genetically engineered hematopoietic stem and T cells bears witness to the substantial improvements in lentiviral vectors over the last two decades, but evaluations of the long-term efficacy and toxicity of gene and cell therapy products will, nevertheless, require further studies in nonhuman primate models. Macaca fascicularis monkeys from Mauritius have a low genetic diversity and are particularly useful for reproducible drug testing. In particular, they have a genetically homogeneous class I major histocompatibility complex system that probably mitigates the variability of the response to simian immunodeficiency virus infection. However, the transduction of simian cells with human immunodeficiency virus type 1 (HIV-1)-derived vectors is inefficient due to capsid-specific restriction factors, such as the tripartite motif-containing protein tripartite motif 5α, which prevent infection with non-host-adapted retroviruses. This study introduced the modified capsid of the macaque-trophic HIV-1 clone MN4/LSQD into the packaging system and compared transduction efficiencies between hematopoietic cells transduced with this construct and cells transduced with HIV-1 NL4-3-derived packaging constructs. Capsid modification increased transduction efficiency in all hematopoietic cells tested (by factors of up to 10), including hematopoietic progenitor cells, repopulating cells, and T cells from Mauritian Macaca fascicularis, regardless of vector structure or purification method. The study also established culture conditions similar to those used in clinical practice for the efficient transduction of hematopoietic stem and progenitor CD34+ cells. These results suggest that the procedure is suitable for use in Mauritian Macaca fascicularis, which can therefore be used as a model in preclinical studies for hematopoietic gene and cell therapy.

journal_name

Hum Gene Ther

journal_title

Human gene therapy

authors

Sii-Felice K,Castillo Padilla J,Relouzat F,Cheuzeville J,Tantawet S,Maouche L,Le Grand R,Leboulch P,Payen E

doi

10.1089/hum.2018.179

subject

Has Abstract

pub_date

2019-10-01 00:00:00

pages

1306-1323

issue

10

eissn

1043-0342

issn

1557-7422

journal_volume

30

pub_type

杂志文章

相关文献

HUMAN GENE THERAPY文献大全
  • Adenoviral gene transfer of sphingosine kinase 1 protects heart against ischemia/reperfusion-induced injury and attenuates its postischemic failure.

    abstract：:Sphingosine kinase 1 (SPK1) has been identified as a central mediator of ischemia preconditioning and plays a protective role in ischemia/reperfusion (I/R)-induced cardiomyocyte death. In the present study, we investigated the protective effect of adenovirus-mediated SPK1 gene (Ad-SPK1) transfer on I/R-induced cardiac...

    journal_title：Human gene therapy

    pub_type： 杂志文章

    doi：10.1089/hum.2007.036

    authors： Duan HF,Wang H,Yi J,Liu HJ,Zhang QW,Li LB,Zhang T,Lu Y,Wu CT,Wang LS

    更新日期：2007-11-01 00:00:00

  • Wnt inhibitory factor-1 gene transfer inhibits melanoma cell growth.

    abstract：:Silencing of Wnt antagonists with aberrant activation of Wnt signaling is a common phenomenon in various human cancers. Wnt inhibitory factor-1 (WIF-1) is a secreted antagonist of Wnt signaling and acts through direct binding to Wnt in the extracellular space. In this study, we tried to illuminate the impact of WIF-1 ...

    journal_title：Human gene therapy

    pub_type： 杂志文章

    doi：10.1089/hum.2006.005

    authors： Lin YC,You L,Xu Z,He B,Yang CT,Chen JK,Mikami I,Clément G,Shi Y,Kuchenbecker K,Okamoto J,Kashani-Sabet M,Jablons DM

    更新日期：2007-04-01 00:00:00

  • Human Bocavirus Type-1 Capsid Facilitates the Transduction of Ferret Airways by Adeno-Associated Virus Genomes.

    abstract：:Human bocavirus type-1 (HBoV1) has a high tropism for the apical membrane of human airway epithelia. The packaging of a recombinant adeno-associated virus 2 (rAAV2) genome into HBoV1 capsid produces a chimeric vector (rAAV2/HBoV1) that also efficiently transduces human airway epithelia. As such, this vector is attract...

    journal_title：Human gene therapy

    pub_type： 杂志文章

    doi：10.1089/hum.2017.060

    authors： Yan Z,Feng Z,Sun X,Zhang Y,Zou W,Wang Z,Jensen-Cody C,Liang B,Park SY,Qiu J,Engelhardt JF

    更新日期：2017-08-01 00:00:00

  • Lentivirus-mediated gene transfer to the central nervous system: therapeutic and research applications.

    abstract：:The management of disorders of the nervous system remains a medical challenge. The key goals are to understand disease mechanisms, to validate therapeutic targets, and to develop new therapeutic strategies. Viral vector-mediated gene transfer can meet these goals and vectors based on lentiviruses have particularly use...

    journal_title：Human gene therapy

    pub_type： 杂志文章,评审

    doi：10.1089/hum.2006.17.1

    authors： Wong LF,Goodhead L,Prat C,Mitrophanous KA,Kingsman SM,Mazarakis ND

    更新日期：2006-01-01 00:00:00

  • Vaccination of women with metastatic breast cancer, using a costimulatory gene (CD80)-modified, HLA-A2-matched, allogeneic, breast cancer cell line: clinical and immunological results.

    abstract：:MDA-MB-231, an HLA-A2(+), HER2/neu(+) allogeneic breast cancer cell line genetically modified to express the costimulatory molecule CD80 (B7-1), was used to vaccinate 30 women with previously treated stage IV breast cancer. Expression of CD80 conferred the ability to deliver a costimulatory signal and thereby improved...

    journal_title：Human gene therapy

    pub_type： 临床试验,杂志文章

    doi：10.1089/104303403322124828

    authors： Dols A,Smith JW 2nd,Meijer SL,Fox BA,Hu HM,Walker E,Rosenheim S,Moudgil T,Doran T,Wood W,Seligman M,Alvord WG,Schoof D,Urba WJ

    更新日期：2003-07-20 00:00:00

  • Inhibitory effect of nuclear factor-κB decoy oligodeoxynucleotide on liver fibrosis through regulation of the epithelial-mesenchymal transition.

    abstract：:The epithelial-mesenchymal transition (EMT) has been recognized to occur during embryonic development, fibrosis, and tumor metastasis. Nuclear factor (NF)-κB plays a central role in mediating the inflammation and wound-healing responses during liver fibrogenesis. However, the involvement of NF-κB during EMT in liver c...

    journal_title：Human gene therapy

    pub_type： 杂志文章

    doi：10.1089/hum.2013.106

    authors： Kim KH,Lee WR,Kang YN,Chang YC,Park KK

    更新日期：2014-08-01 00:00:00

  • Clinical-scale selection of anti-CD3/CD28-activated T cells after transduction with a retroviral vector expressing herpes simplex virus thymidine kinase and truncated nerve growth factor receptor.

    abstract：:Activation of T cells is necessary for efficient retroviral-mediated gene transfer. In addition, if the population of infused cells is to be limited to transduced cells, a means of positive selection is required. We describe a clinical scale procedure for activation of donor T cells with anti-CD3/CD28 beads followed b...

    journal_title：Human gene therapy

    pub_type： 杂志文章

    doi：10.1089/10430340252939087

    authors： Orchard PJ,Blazar BR,Burger S,Levine B,Basso L,Nelson DM,Gordon K,McIvor RS,Wagner JE,Miller JS

    更新日期：2002-05-20 00:00:00

  • Adipose tissue as a novel target for in vivo gene transfer by adeno-associated viral vectors.

    abstract：:Traditionally, skeletal muscle and liver are the preferred target organs for gene transfer to supply a transgene product into the systemic circulation. In this respect, adipose tissue presents a number of attractive features. However, adipose tissue transduction in vivo has not been feasible by conventional methods. T...

    journal_title：Human gene therapy

    pub_type： 杂志文章

    doi：10.1089/hum.2006.17.921

    authors： Mizukami H,Mimuro J,Ogura T,Okada T,Urabe M,Kume A,Sakata Y,Ozawa K

    更新日期：2006-09-01 00:00:00

  • Preclinical safety and biodistribution of adenovirus-based cancer vaccines after intradermal delivery.

    abstract：:The recombinant adenoviral (Ad) vector is being considered as a cancer vaccine platform because it efficiently induces immune responses to tumor antigens by intradermal immunization. The aims of this study were to evaluate the potential toxicities and biodistribution after a single dose or six weekly intradermal doses...

    journal_title：Human gene therapy

    pub_type： 杂志文章

    doi：10.1089/hum.2006.17.705

    authors： Plog MS,Guyre CA,Roberts BL,Goldberg M,St George JA,Perricone MA

    更新日期：2006-07-01 00:00:00

  • Comparative analysis of antisense oligonucleotide sequences for targeted skipping of exon 51 during dystrophin pre-mRNA splicing in human muscle.

    abstract：:Duchenne muscular dystrophy (DMD) is caused by mutations in the dystrophin gene that result in the absence of functional protein. In the majority of cases these are out-of-frame deletions that disrupt the reading frame. Several attempts have been made to restore the dystrophin mRNA reading frame by modulation of pre-m...

    journal_title：Human gene therapy

    pub_type： 杂志文章

    doi：10.1089/hum.2006.061

    authors： Arechavala-Gomeza V,Graham IR,Popplewell LJ,Adams AM,Aartsma-Rus A,Kinali M,Morgan JE,van Deutekom JC,Wilton SD,Dickson G,Muntoni F

    更新日期：2007-09-01 00:00:00

  • Factors associated with induced chronic inflammation in mdx skeletal muscle cause posttranslational stabilization and augmentation of extrasynaptic sarcolemmal utrophin.

    abstract：:Chronic inflammation in tibialis anterior muscles of mdx mice was produced by a single injection of a recombinant adenovirus vector (AV) expressing an immunogenic beta-galactosidase (beta-gal). In regions of intense beta-gal staining, mononuclear infiltrates abounded, and muscle fibers showed strong extrasynaptic utro...

    journal_title：Human gene therapy

    pub_type： 杂志文章

    doi：10.1089/hum.2005.16.489

    authors： Waheed I,Gilbert R,Nalbantoglu J,Guibinga GH,Petrof BJ,Karpati G

    更新日期：2005-04-01 00:00:00

  • Phase I/II study of oncolytic herpes simplex virus NV1020 in patients with extensively pretreated refractory colorectal cancer metastatic to the liver.

    abstract：:This multicenter phase I/II study evaluated the safety, pharmacokinetics, and antitumor effects of repeated doses of NV1020, a genetically engineered oncolytic herpes simplex virus, in patients with advanced metastatic colorectal cancer (mCRC). Patients with liver-dominant mCRC received four fixed NV1020 doses via wee...

    journal_title：Human gene therapy

    pub_type： 杂志文章,多中心研究

    doi：10.1089/hum.2010.020

    authors： Geevarghese SK,Geller DA,de Haan HA,Hörer M,Knoll AE,Mescheder A,Nemunaitis J,Reid TR,Sze DY,Tanabe KK,Tawfik H

    更新日期：2010-09-01 00:00:00

  • Generating and regulating immune responses through cutaneous gene delivery.

    abstract：:The combination of immunization strategies with gene therapy methods constitutes a powerful tool for the purpose of genetic immunization. The cutaneous microenvironment, rich in professional antigen-presenting cells and accessory cells capable of initiating and controlling the intensity of specific immune responses, m...

    journal_title：Human gene therapy

    pub_type： 杂志文章,评审

    doi：10.1089/104303400750035852

    authors： Larregina AT,Falo LD Jr

    更新日期：2000-11-01 00:00:00

  • Tumor-targeting nanoimmunoliposome complex for short interfering RNA delivery.

    abstract：:The potential of short interfering RNA (siRNA) to be developed for therapeutic use against cancer depends on the availability of an efficient tumor-specific delivery vehicle. We have previously shown that a nanoscale nonviral liposome-based complex that includes an anti-transferrin receptor single-chain antibody fragm...

    journal_title：Human gene therapy

    pub_type： 杂志文章

    doi：10.1089/hum.2006.17.117

    authors： Pirollo KF,Zon G,Rait A,Zhou Q,Yu W,Hogrefe R,Chang EH

    更新日期：2006-01-01 00:00:00

  • Improved gene transfer into human lymphocytes using retroviruses with the gibbon ape leukemia virus envelope.

    abstract：:Gene-modified lymphocytes have a potential role in the therapy of cancer, infectious diseases, and genetic disorders of the immune system. Current gene therapy protocols involving gene transfer into lymphocytes utilize retroviruses with amphotropic envelope proteins. However, transduction efficiencies in lymphocytes u...

    journal_title：Human gene therapy

    pub_type： 杂志文章

    doi：10.1089/hum.1996.7.12-1415

    authors： Lam JS,Reeves ME,Cowherd R,Rosenberg SA,Hwu P

    更新日期：1996-08-01 00:00:00

  • Evaluating Nonintegrating Lentiviruses as Safe Vectors for Noninvasive Reporter-Based Molecular Imaging of Multipotent Mesenchymal Stem Cells.

    abstract：:Reporter gene-based molecular imaging can provide invaluable information on the fate of cellular therapies postimplantation. Integrating lentiviral vectors (ILVs) are commonly used for stably engineering cells; however, their potential for insertional mutagenesis poses a significant safety concern and barrier to wides...

    journal_title：Human gene therapy

    pub_type： 杂志文章

    doi：10.1089/hum.2018.111

    authors： Hamilton AM,Foster PJ,Ronald JA

    更新日期：2018-10-01 00:00:00

  • Chimeric Antigen Receptors in Different Cell Types: New Vehicles Join the Race.

    abstract：:Adoptive cellular therapy has evolved into a powerful force in the battle against cancer, holding promise for curative responses in patients with advanced and refractory tumors. Autologous T cells, reprogrammed to target malignant cells via the expression of a chimeric antigen receptor (CAR) represent the frontrunner ...

    journal_title：Human gene therapy

    pub_type： 杂志文章,评审

    doi：10.1089/hum.2017.236

    authors： Harrer DC,Dörrie J,Schaft N

    更新日期：2018-05-01 00:00:00

  • Herpesvirus vector-mediated gene delivery to human monocytes.

    abstract：:In vitro delivery of interferon-alpha (IFN-alpha) to cultured human monocytes by means of a replication-incompetent herpesvirus vector inhibits human immunodeficiency virus (HIV) replication. To explore the possibility of IFN-alpha gene delivery by vector-infected human monocytes, monocytes were isolated and the cultu...

    journal_title：Human gene therapy

    pub_type： 杂志文章

    doi：10.1089/hum.1996.7.11-1331

    authors： Weir JP,Dacquel EJ,Aronovitz J

    更新日期：1996-07-10 00:00:00

  • PEGylation of E1-deleted adenovirus vectors allows significant gene expression on readministration to liver.

    abstract：:Systemic administration of adenoviral vectors leads to activation of innate and antigen-specific immunity. In an attempt to diminish T and B cell-specific immune responses to E1-deleted adenoviral vectors, capsid proteins were modified with various activated monomethoxypolyethylene glycols (MPEGs). The impact of this ...

    journal_title：Human gene therapy

    pub_type： 杂志文章

    doi：10.1089/104303402760372972

    authors： Croyle MA,Chirmule N,Zhang Y,Wilson JM

    更新日期：2002-10-10 00:00:00

  • Mitochondrial gene therapy augments mitochondrial physiology in a Parkinson's disease cell model.

    abstract：:Neurodegeneration in Parkinson's disease (PD) affects mainly dopaminergic neurons in the substantia nigra, where age-related, increasing percentages of cells lose detectable respiratory activity associated with depletion of intact mitochondrial DNA (mtDNA). Replenishment of mtDNA might improve neuronal bioenergetic fu...

    journal_title：Human gene therapy

    pub_type： 杂志文章

    doi：10.1089/hum.2009.023

    authors： Keeney PM,Quigley CK,Dunham LD,Papageorge CM,Iyer S,Thomas RR,Schwarz KM,Trimmer PA,Khan SM,Portell FR,Bergquist KE,Bennett JP Jr

    更新日期：2009-08-01 00:00:00

  • Recombinant adeno-associated viral vectors in the nervous system.

    abstract：:Recombinant adeno-associated virus 2 (rAAV2) has been extensively used as a gene delivery vector for the nervous system. It targets primarily neurons in the nervous system and results in sustained long-term expression of transgenes. New rAAV serotypes have been characterized and demonstrated to have improved transduct...

    journal_title：Human gene therapy

    pub_type： 杂志文章,评审

    doi：10.1089/hum.2005.16.781

    authors： Burger C,Nash K,Mandel RJ

    更新日期：2005-07-01 00:00:00

  • Helper-dependent adenoviral vectors containing modified fiber for improved transduction of developing and mature muscle cells.

    abstract：:Adenoviruses (Ads) have shown great utility as vectors for the delivery of genes to mammalian cells, partly because of their ability to infect a wide range of different cell types independent of the replicative state of the cell. However, Ads do not transduce mature muscle efficiently because of low levels of the natu...

    journal_title：Human gene therapy

    pub_type： 杂志文章

    doi：10.1089/104303404772679986

    authors： Bramson JL,Grinshtein N,Meulenbroek RA,Lunde J,Kottachchi D,Lorimer IA,Jasmin BJ,Parks RJ

    更新日期：2004-02-01 00:00:00

  • Self-selection by genetically modified committed lymphocyte precursors reverses the phenotype of JAK3-deficient mice without myeloablation.

    abstract：:Janus kinase 3 (JAK3) is an essential component of cytokine receptor signal transduction pathways required for normal lymphocyte development and function. JAK3 deficiency in both mice and humans results in severe combined immunodeficiency (SCID) and increased susceptibility to opportunistic infections. We have previou...

    journal_title：Human gene therapy

    pub_type： 杂志文章

    doi：10.1089/104303400750038462

    authors： Bunting KD,Lu T,Kelly PF,Sorrentino BP

    更新日期：2000-11-20 00:00:00

  • Inhibition of human immunodeficiency virus replication and growth advantage of CD4+ T cells from HIV-infected individuals that express intracellular antibodies against HIV-1 gp120 or Tat.

    abstract：:Current clinical gene therapy protocols for the treatment of human immunodeficiency virus type 1 (HIV-1) infection often involve the ex vivo transduction and expansion of CD4+ T cells derived from HIV-positive patients at a late stage in their disease (CD4 count <400). These protocols involve the transduction of T cel...

    journal_title：Human gene therapy

    pub_type： 杂志文章

    doi：10.1089/hum.1998.9.4-487

    authors： Poznansky MC,Foxall R,Mhashilkar A,Coker R,Jones S,Ramstedt U,Marasco W

    更新日期：1998-03-01 00:00:00

  • Monogene and polygene therapy for the treatment of experimental prostate cancers by use of apoptotic genes bax and bad driven by the prostate-specific promoter ARR(2)PB.

    abstract：:We have shown that adenovirus-mediated manipulation of apoptotic genes such as bax could be a therapeutic option for prostate cancer. Unfortunately, the response of experimental prostate tumors to a single therapeutic gene of the apoptotic pathway is short-lived, and most of these tumors relapse after a short period o...

    journal_title：Human gene therapy

    pub_type： 杂志文章

    doi：10.1089/10430340260395901

    authors： Zhang Y,Yu J,Unni E,Shao TC,Nan B,Snabboon T,Kasper S,Andriani F,Denner L,Marcelli M

    更新日期：2002-11-20 00:00:00

  • Engineered U7 Small Nuclear RNA Restores Correct β-Globin Pre-mRNA Splicing in Mouse βIVS2-654-Thalassemic Erythroid Progenitor Cells.

    abstract：:Restoration of correct splicing of βIVS2-654-globin pre-mRNA was previously accomplished in erythroid cells from β-thalassemia/HbE patients by an engineered U7 small nuclear RNA (snRNA) that carried a sequence targeted to the cryptic branch point and an exonic splicing enhancer, U7.BP+623 snRNA. In this study, this ap...

    journal_title：Human gene therapy

    pub_type： 杂志文章

    doi：10.1089/hum.2020.145

    authors： d'Arqom A,Nualkaew T,Jearawiriyapaisarn N,Kole R,Svasti S

    更新日期：2020-11-02 00:00:00

  • E1A- and E1B-Double mutant replicating adenovirus elicits enhanced oncolytic and antitumor effects.

    abstract：:Gene-modified replication-competent adenoviruses (Ads) are emerging as a promising new modality for the treatment of cancer. We have previously shown that E1B 19kDa and E1B 55kDa gene-deleted Ad (Ad-DeltaE1B19/55) exhibits improved tumor-specific replication and cell lysis, leading to an enhanced antitumor effect. In ...

    journal_title：Human gene therapy

    pub_type： 杂志文章

    doi：10.1089/hum.2006.167

    authors： Kim J,Kim JH,Choi KJ,Kim PH,Yun CO

    更新日期：2007-09-01 00:00:00

  • Extracellular vesicles as enhancers of virus vector-mediated gene delivery.

    abstract：:Extracellular vesicles (EVs) being released from two adjacent adeno-associated virus serotype 1 (AAV1)-producing 293T cells are shown by electron microscopy. We have shown that AAV vectors can associate with EVs and enter the media. Furthermore, we have recently reported that EV-associated AAV has robust gene delivery...

    journal_title：Human gene therapy

    pub_type： 杂志文章

    doi：10.1089/hum.2014.082

    authors： Fitzpatrick Z,György B,Skog J,Maguire CA

    更新日期：2014-09-01 00:00:00

  • In vivo marking of spontaneous or vaccine-induced fibrosarcomas in the domestic house cat, using an adenoviral vector containing a bifunctional fusion protein, GAL-TEK.

    abstract：:We evaluated the ability of a replication-deficient, recombinant adenoviral vector to transfer the bifunctional gene GAL-TEK, which expresses a marking/therapeutic gene product, to naturally occurring cat fibrosarcomas in situ. GAL-TEK contains an in-frame fusion of the bacterial LacZ gene for histochemical marking of...

    journal_title：Human gene therapy

    pub_type： 杂志文章

    doi：10.1089/hum.1995.6.9-1215

    authors： Marini FC 3rd,Cannon JP,Belmont JW,Shillitoe EJ,Lapeyre JN

    更新日期：1995-09-01 00:00:00

  • Potential of allospecific gene-engineered T cells in transplantation gene therapy: specific T cell activation determines transgene expression in vitro and in vivo.

    abstract：:T lymphocytes, regardless of their specificity, are considered key targets for genetic modification in the treatment of inherited or acquired human diseases. In this study, we generated Lewis T cell lines specific for Dark Agouti rat alloantigens and tested the potential of allospecific T lymphocytes as carriers of ge...

    journal_title：Human gene therapy

    pub_type： 杂志文章

    doi：10.1089/10430340050032401

    authors： Hammer MH,Flügel A,Seifert M,Lehmann M,Brandt C,Volk HD,Ritter T

    更新日期：2000-06-10 00:00:00